08:59 AM EDT, 06/18/2025 (MT Newswires) -- Health care stocks were mixed premarket Wednesday, with the Health Care Select Sector SPDR Fund (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) 0.4% higher recently.

Scholar Rock Holding ( SRRK ) shares were advancing by more than 5% after the company said a phase 2 trial showed that apitegromab combined with tirzepatide achieved a 54.9% preservation of lean mass compared with tirzepatide alone, leading to higher-quality weight loss.